A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response

por Vestermark, LW, Holtved, E, Dahlrot, R, Brimnes, MK, Svane, IM, Bastholt, L
Publicado 2008

Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model

por Schmidt, H, Bastholt, L, Geertsen, P, Christensen, I J, Larsen, S, Gehl, J, von der Maase, H
Publicado 2005

Surgery and radiotherapy in the treatment of cutaneous melanoma

por Testori, A., Rutkowski, P., Marsden, J., Bastholt, L., Chiarion-Sileni, V., Hauschild, A., Eggermont, A. M. M.
Publicado 2009

Immunotherapy of distant metastatic disease

por Schadendorf, D., Algarra, S. M., Bastholt, L., Cinat, G., Dreno, B., Eggermont, A. M. M., Espinosa, E., Guo, J., Hauschild, A., Petrella, T., Schachter, J., Hersey, P.
Publicado 2009

Small molecules and targeted therapies in distant metastatic disease

por Hersey, P., Bastholt, L., Chiarion-Sileni, V., Cinat, G., Dummer, R., Eggermont, A. M. M., Espinosa, E., Hauschild, A., Quirt, I., Robert, C., Schadendorf, D.
Publicado 2009